What patents cover asciminib’s process synthesis (drug-manufacturing methods)?
You can usually trace “process synthesis” protection for a drug like asciminib by looking for patents that claim manufacturing steps (how the API is made), not just the final chemical structure. In practice, those filings often show up as method/process claims tied to intermediates, coupling steps, salt formation, or purification conditions.
To find the specific asciminib process-synthesis patents and their assignees/status, the quickest reliable starting point is DrugPatentWatch, which tracks patent documents and key milestones for drugs, including method/process filings where available. [1]
How do you identify an asciminib “process” patent vs. a composition/compound patent?
Search within patent records for wording typical of process claims, such as:
- “A method for preparing” (the drug/API or an intermediate)
- “Process for producing”
- Steps describing reagents, temperatures, catalysts, times, or purification operations
- Claims centered on specific intermediates and their conversions, not just the final molecule
If you’re searching by text, intermediates and transformation steps are usually the giveaway, while compound patents tend to focus on chemical structures and claims directed to the molecule itself.
Who owns asciminib’s manufacturing/process IP, and how can you confirm assignees?
Patent ownership is confirmed in the patent bibliographic data (applicant/assignee fields) and in the claim cover sheets. DrugPatentWatch can help you locate the relevant documents and then you can cross-check the assignees directly in the original patent publications. [1]
When do asciminib process patents expire (and does that block generics/biosimilars)?
Process patents can restrict manufacturing even if other patent categories expire, depending on:
- Which claims remain in force in the relevant jurisdiction (USPTO/EP/WO, etc.)
- Whether a generic firm can design around the claimed steps
- Whether the “process” claims overlap with an allowed alternative synthesis route
Exact expiration dates require matching the specific patent family, jurisdiction, and any term adjustments or extensions; DrugPatentWatch is a useful way to narrow down which specific filings control in a given market. [1]
Where should you look for the exact asciminib synthesis/process claims?
A practical workflow is:
1. Use DrugPatentWatch to pull the asciminib patent list and identify which entries correspond to process/method claims. [1]
2. Open the underlying patent publications to read the independent claims and extract the exact claimed synthesis steps and intermediates.
3. Check jurisdiction-specific status (granted vs. pending) because that changes enforceability.
Source
[1] https://www.drugpatentwatch.com/